1211 – Cancer incidence and mortality among 457,473 persons with type 2 diabetes compared to 2,287,365 matched controls in Sweden: an observational study – H.H. Bjornsdottir, S. Franzén, A. Rawshani, A. Rawshani, N. Sattar, A.-M. Svensson, S. Gudbjornsdottir, Sweden, Iceland, UK

1212 – Prospective cohort study of type 2 diabetes and the risk of cancer in Japan: 5-year interim report – K. Tsuneda, A. Yoshikawa, K. Okita, Y. Inui, S. Fujita, M. Takahara, Iwahashi, S. Kurebayashi, H. Konya, A. Otsuka, N. Handa, T. Fukui, H. Matsushima, N. Watanabe, S. Kawata, Japan

1213 – Insulin sensitivity in diabetes associated with pancreatic cancer – P. Skrha, P. Fric, J. Uhrova, M. Andel, J. Skrha, Czech Republic

1214 – Insulin resistance and colon epithelial proliferation – L. Kedenko, J. Mayböck, C. Kronberger, T. Kiesslich, I. Kedenko, B. Paulweber, G. Wolkersdörfer, Austria

1215 – Obesity, glucose abnormalities and metabolic syndrome are hallmarks of well differentiated nets – A.P. Santos, C. Castro, I. Torres, R. Henrique, M.H. Cardoso, M.P. Monteiro, Portugal

1216 – Glucose enhances breast cancer cell aggressiveness via adipose-derived mesenchymal stem cells – V. D’Esposito, G. Mosca, M. Ambrosio, T. Migliaccio, S. Cabaro, N. Prevete, Piccolo, A. Maione, L. Albano, F. D’Andrea, F. Beguinot, P. Formisano, Italy

1217 – The phosphorylation of Akt through mTORC2 a possible link between dietary AGEs, diabetes and colorectal cancer – A.I. Serban, O.I. Geicu, L. Stanca, A. Dinischiotu, Romania

1218 – Endogenous insulin hypersecretion links diet-induced obesity to pancreatic cancer development in Ptf1aCreER;LSL-KrasG12D mice – A. Zhang, X. Hu, J. Magrill, J.L. Kopp, J.D. Johnson, Canada